市場調査レポート
商品コード
1447713

遠隔患者モニタリング市場:製品別、用途別、エンドユーザー別 - 2031年までの世界予測

Remote Patient Monitoring Market by Product ( ) Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders) End User - Global Forecast to 2031

出版日: | 発行: Meticulous Research | ページ情報: 英文 247 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
遠隔患者モニタリング市場:製品別、用途別、エンドユーザー別 - 2031年までの世界予測
出版日: 2024年03月08日
発行: Meticulous Research
ページ情報: 英文 247 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遠隔患者モニタリング市場は、2024年から2031年にかけて13.7%のCAGRで、2031年までに1,168億4,000万米ドルに達すると予測されます。

本レポートでは、包括的な一次調査および二次調査と市場シナリオの詳細な分析に基づき、業界の主要促進要因・抑制要因・課題・機会を提供しています。この市場は、高齢者人口の増加、慢性疾患の有病率の上昇、ヘルスケア専門家の不足、利便性や患者の転帰の改善といったRPMの利点に関する意識の高まり、医療費削減ニーズの高まり、遠隔患者モニタリングを推進する政府の有利な取り組みなどが原動力となっています。

さらに、遠隔医療と遠隔患者モニタリングの技術的進歩、患者数が増加している新興国、ウェアラブルデバイスの採用増加、センサー技術の進歩、人工知能とRPMの統合は、この市場に大きな成長機会を提供しています。しかし、データの正確性と信頼性への懸念、アクセス制限など遠隔患者モニタリング技術の使用を制限する障壁、患者の技術リテラシーの低さが市場の成長を抑制しています。さらに、データのセキュリティとプライバシーに関する懸念や、RPMシステムを管理するためにスタッフを増員する必要があることによる諸経費の増加が、市場の課題となっています。

製品別では、2024年にはモニタリング機器分野が遠隔患者モニタリング市場で最大のシェアを占めると予想されます。このセグメントの大きなシェアは、さまざまな慢性疾患の有病率の増加、高齢者人口の増加、有利な規制シナリオ、センサー技術の技術的進歩、個別化ヘルスケアの需要の高まり、モニタリング機器への人工知能と機械学習の統合などの要因によるものです。

用途別では、2024年には糖尿病分野が遠隔患者モニタリング市場で最大のシェアを占めると予想されています。糖尿病は従来、主に遺伝性の疾患と見なされてきたが、その急速な流行により、生活習慣に関連した疾患として認識されるようになってきています。このセグメントの大きなシェアは、糖尿病管理における遠隔医療の利用、糖尿病有病率の増加、糖尿病患者をモニタリングする必要性の増加などの要因によるものです。

エンドユーザー別では、2024年には在宅医療分野が遠隔患者モニタリング市場で最大のシェアを占めると予想されています。このセグメントの市場シェアが大きいのは、在宅ケア環境へのシフトが進んでいること、高齢者の慢性疾患の増加、医療専門家の不足、RPMツールによる慢性疾患のモニタリングに関する消費者の意識の高まりなどが背景にあります。

世界の遠隔患者モニタリング市場の地域別シナリオの詳細分析では、主要5地域の詳細な質的・量的洞察を提供しています。2024年には、北米が世界の遠隔患者モニタリング市場で最大のシェアを占め、次いで欧州、アジア太平洋、ラテンアメリカ、中東・アフリカが続くと予想されています。アジア太平洋は、世界の遠隔患者モニタリング市場で最も急成長している地域になると予想されています。この成長は主に、ヘルスケア支出の増加、高齢者人口の増加、慢性疾患の有病率の上昇、消費者意識の高まり、個人の可処分所得の増加、対象人口の多さによってもたらされ、市場の成長を支えています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

  • 市場
  • 概要
  • 市場成長への影響要因
    • 市場力学の影響分析
    • 要因分析
  • 遠隔患者モニタリング市場の規制分析
    • 概要
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東
  • 価格分析
  • 業界動向
    • 医師主導から消費者主導へのヘルスケアシフト
    • 人工知能と遠隔患者モニタリング技術の統合
  • ポーターのファイブフォース分析

第5章 遠隔患者モニタリング市場評価:製品別

  • 概要
  • モニタリング機器
    • モニタリング機器:機能別
    • モニタリング装置:タイプ別
  • ソフトウェア
  • サービス

第6章 遠隔患者モニタリング市場評価:用途別

  • 概要
  • 糖尿病
  • 心血管疾患
  • 神経疾患
  • 呼吸器疾患
  • 腫瘍学
  • その他の応用

第7章 遠隔患者モニタリング市場評価:エンドユーザー別

  • 概要
  • 在宅介護施設
  • 長期介護施設
  • 病院
  • その他のエンドユーザー

第8章 遠隔患者モニタリング市場評価:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合分析

  • 概要
  • 主要成長戦略
  • 競合ベンチマーキング
  • 競合ダッシュボード
    • 業界リーダー
    • 市場差別化要因
    • 先行企業
    • 新興企業

第10章 企業プロファイル

  • Medtronic plc
  • Koninklijke Philips N.V.
  • Omron Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Ge Healthcare Technologies, Inc.
  • F. Hoffmann-La Roche AG
  • Baxter International Inc.
  • Oracle Corporation
  • Dexcom, Inc.
  • VitalConnect, Inc.
  • Other Companies

第11章 付録

図表
  • Table 1 Population Aged 65 or Above, by Region, 2019 Vs. 2030 Vs. 2050 (In Million)
  • Table 2 Total Deaths Due to Parkinson's And Alzheimer's, by Country, 2010 Vs. 2019 Vs. 2020
  • Table 3 Total Deaths Due to Respiratory Disorders (Influenza, Pneumonia, COPD, Asthma), by Country, 2010 Vs. 2019 Vs. 2020
  • Table 4 Total Deaths Due to Circulatory System Diseases (Ischemic Heart Disease, Cerebrovascular Diseases), by Country, 2010 Vs. 2019 Vs. 2020
  • Table 5 Recent Technological Developments in Remote Patient Monitoring
  • Table 6 Physicians Per 1000 People, by Country, 2020
  • Table 7 Hospital Beds Per 1000 People, by Country, 2020
  • Table 8 Remote Patient Monitoring Devices: FDA Medical Device Classification
  • Table 9 China's Medical Device Classification Management System
  • Table 10 Saudi Arabia: Medical Device Classification System
  • Table 11 Remote Patient Monitoring Devices: Pricing Analysis
  • Table 12 Remote Patient Monitoring Services: Pricing Model
  • Table 13 Global Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 14 Global Remote Patient Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Remote Patient Monitoring Devices Market, by Functionality, 2022-2031 (USD Million)
  • Table 16 Number of People With Diabetes, by Region (2021 Vs. 2030) (In Thousands)
  • Table 17 Global Blood Glucose Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Some of The Examples of Wearable Cardiac Monitoring Devices
  • Table 19 Some of The Examples of Implantable Cardiac Monitoring Devices
  • Table 20 Global Cardiac Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global Neurological Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Respiratory Monitoring Devices, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Multiparameter Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Global Blood Pressure Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Number of Childbirths Per Year (2020 Vs. 2030)
  • Table 26 Global Fetal And Neonatal Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global Weight Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 28 Global Other Remote Patient Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 29 Global Remote Patient Monitoring Devices, by Type, 2022-2031 (USD Million)
  • Table 30 Innovative Wearable Remote Patient Monitoring Devices
  • Table 31 Global Wearable Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Portable Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global Bench-Top Remote Patient Monitoring Devices Market, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Major Features of Remote Patient Monitoring Software
  • Table 35 Global Remote Patient Monitoring Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Types of Services Involved in Remote Patient Monitoring
  • Table 37 Trends in The Services Segment
  • Table 38 Global Remote Patient Monitoring Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 40 Some of The Companies Offering Remote Patient Monitoring For Diabetes
  • Table 41 Global Remote Patient Monitoring Market For Diabetes, by Country/Region, 2022-2031 (USD Million)
  • Table 42 Some of The Companies Offering Remote Patient Monitoring For Cardiovascular Diseases
  • Table 43 Global Remote Patient Monitoring Market For Cardiovascular Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 44 Burden of Neurological Conditions (Dalys Per 100,000 Population)
  • Table 45 Deaths Per 100,000 Population Due to Parkinson's Disease And Alzheimer
  • Table 46 Some of The Companies Offering Remote Patient Monitoring For Neurological Disorders
  • Table 47 Global Remote Patient Monitoring Market For Neurological Disorders, by Country/Region, 2022-2031 (USD Million)
  • Table 48 Some of The Companies Offering Remote Patient Monitoring For Respiratory Diseases
  • Table 49 Global Remote Patient Monitoring Market For Respiratory Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 50 Some of The Companies Offering Remote Patient Monitoring For Oncology
  • Table 51 Global Remote Patient Monitoring Market For Cancer, by Country/Region, 2022-2031 (USD Million)
  • Table 52 Some of The Companies Offering Remote Patient Monitoring For Other Applications
  • Table 53 Global Remote Patient Monitoring Market For Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 54 Global Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 55 Global Remote Patient Monitoring Market For Home-Care Settings, by Country/Region, 2022-2031 (USD Million)
  • Table 56 Global Remote Patient Monitoring Market For Long-Term Care Facilities, by Country/Region, 2022-2031 (USD Million)
  • Table 57 Global Remote Patient Monitoring Market For Hospitals, by Country/Region, 2022-2031 (USD Million)
  • Table 58 Global Remote Patient Monitoring Market For Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 59 Global Remote Patient Monitoring Market, by Country/Region, 2022-2031 (USD Million)
  • Table 60 North America: Remote Patient Monitoring Market, by Country, 2022-2031 (USD Million)
  • Table 61 North America: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 62 North America: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 63 North America: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 64 North America: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 65 North America: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 66 U.S.: Macro Indicators & Micro Indicators
  • Table 67 U.S.: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 68 U.S.: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 69 U.S.: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 70 U.S.: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 71 U.S.: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 72 Canada: Macroeconomic Indicators
  • Table 73 Canada: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 74 Canada: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 75 Canada: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 76 Canada: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 77 Canada: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 78 Europe: Remote Patient Monitoring Market, by Country/Region, 2022-2031 (USD Million)
  • Table 79 Europe: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 80 Europe: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 81 Europe: Remote Patient Monitoring Market, by Type, 2022-2031 (USD Million)
  • Table 82 Europe: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 83 Europe: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 84 Germany: Macroeconomic Indicators
  • Table 85 Germany: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 86 Germany: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 87 Germany: Remote Patient Monitoring Devices, by Type, 2022-2031 (USD Million)
  • Table 88 Germany: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 89 Germany: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 90 U.K.: Prevalence of Various Chronic Conditions
  • Table 91 U.K.: Macroeconomic Indicators
  • Table 92 U.K.: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 93 U.K.: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 94 U.K.: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 95 U.K.: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 96 U.K.: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 97 France: Macroeconomic Indicators
  • Table 98 France: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 99 France: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 100 France: Remote Patient Monitoring Market, by Type, 2022-2031 (USD Million)
  • Table 101 France: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 102 France: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 103 Italy: Leading Causes of Deaths (2020)
  • Table 104 Italy: Macroeconomic Indicators
  • Table 105 Italy: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 106 Italy: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 107 Italy: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 108 Italy: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 109 Italy: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 110 Spain: Macroeconomic Indicators
  • Table 111 Spain: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 112 Spain: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 113 Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 114 Spain: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 115 Spain: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 116 Rest of Europe: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 117 Rest of Europe: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 118 Rest of Europe: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 119 Rest of Europe: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 120 Rest of Europe: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 121 Asia-Pacific: Remote Patient Monitoring Market, by Country/Region, 2022-2031 (USD Million)
  • Table 122 Asia-Pacific: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 123 Asia-Pacific: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 124 Asia-Pacific: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 125 Asia-Pacific: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 126 Asia-Pacific: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 127 China: Macroeconomic Indicators
  • Table 128 China: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 129 China: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 130 China: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 131 China: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 132 China: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 133 Japan: Macroeconomic Indicators
  • Table 134 Japan: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 135 Japan: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 136 Japan: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 137 Japan: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 138 Japan: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 139 India: Macroeconomic Indicators
  • Table 140 India: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 141 India: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 142 India: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 143 India: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 144 India: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 145 Rest of Asia-Pacific: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 146 Rest of Asia-Pacific: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 147 Rest of Asia-Pacific: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 148 Rest of Asia-Pacific: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 149 Rest of Asia-Pacific: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 150 Latin America: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 151 Latin America: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 152 Latin America: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 153 Latin America: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 154 Latin America: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 155 Middle East & Africa: Remote Patient Monitoring Market, by Product, 2022-2031 (USD Million)
  • Table 156 Middle East & Africa: Remote Patient Monitoring Devices Market, by Function, 2022-2031 (USD Million)
  • Table 157 Middle East & Africa: Remote Patient Monitoring Devices Market, by Type, 2022-2031 (USD Million)
  • Table 158 Middle East & Africa: Remote Patient Monitoring Market, by Application, 2022-2031 (USD Million)
  • Table 159 Middle East & Africa: Remote Patient Monitoring Market, by End User, 2022-2031 (USD Million)
  • Table 160 Recent Developments, by Company, 2020-2024
  • Table 161 Product Portfolio Analysis

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for This Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Remote Patient Monitoring Market Size, by Product, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Remote Patient Monitoring Market Size, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Remote Patient Monitoring Market Size, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 10 Remote Patient Monitoring Market, by Geography
  • Figure 11 Impact Analysis of Market Dynamics
  • Figure 12 Global Estimated Number of New Cancer Cases, 2020-2040
  • Figure 13 Benefits of Remote Patient Monitoring
  • Figure 14 Global Prevalence of Diabetes in People Aged 20-79 Years, 2011-2045
  • Figure 15 USFDA Regulatory Pathways For Medical Devices
  • Figure 16 Eu Regulatory Pathway - IVDR 2017/746
  • Figure 17 China: Medical Device Classification And Pre-Market Requirements For IVD Devices
  • Figure 18 Advantages of AI Integration in Remote Patient Monitoring
  • Figure 19 Porter's Five Forces Analysis
  • Figure 20 Global Remote Patient Monitoring Market, by Product, 2024 Vs. 2031 (USD Million)
  • Figure 21 Global Remote Patient Monitoring Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 22 Estimated Number of Cancer Cases (2020-2040)
  • Figure 23 Global Remote Patient Monitoring Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 24 Global Remote Patient Monitoring Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 25 North America: Remote Patient Monitoring Market Snapshot
  • Figure 26 Geriatric Population in Canada (2019-2050)
  • Figure 27 Europe: Remote Patient Monitoring Market Snapshot
  • Figure 28 Asia-Pacific: Remote Patient Monitoring Market Snapshot
  • Figure 29 China: Estimated Number of New Cancer Cases (2020-2040)
  • Figure 30 Japan: Percentage of Population Aged 65 And Above (2010-2030)
  • Figure 31 Key Growth Strategies Adopted by Leading Players, 2020-2023
  • Figure 32 Remote Patient Monitoring Market: Competitive Benchmarking by Region
  • Figure 33 Competitive Dashboard: Remote Patient Monitoring Market
  • Figure 34 Medtronic plc: Financial Overview (2022)
  • Figure 35 Koninklijke Philips N.V.: Financial Overview (2022)
  • Figure 36 OMRON Corporation: Financial Overview (2022)
  • Figure 37 Boston Scientific Corporation: Financial Overview (2022)
  • Figure 38 Abbott Laboratories: Financial Overview (2022)
  • Figure 39 Siemens Healthineers AG: Financial Overview (2022)
  • Figure 40 GE Healthcare Technologies, Inc.: Financial Overview (2023)
  • Figure 41 F. Hoffmann-La Roche AG: Financial Overview (2023)
  • Figure 42 Baxter International, Inc.: Financial Overview (2023)
  • Figure 43 Oracle Corporation: Financial Overview (2022)
  • Figure 44 DexCom, Inc.: Financial Overview (2023)
目次
Product Code: MRHC - 104658

Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]), Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders), End User-Global Forecast to 2031

The global remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, restraints, challenges, and opportunities of the industry. This market is driven by the increasing geriatric population, rising prevalence of chronic diseases, shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring.

Furthermore, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence with RPM provide a significant growth opportunity for this market. However, data accuracy & reliability concerns, barriers limiting the use of remote patient monitoring technologies such as limited access, and low technology literacy among patients restrain the growth of the market. Additionally, data security & privacy concerns and increased overhead expenses due to the need for additional staff to manage the RPM system are challenging factors in the market.

Among products, in 2024, the monitoring devices segment is expected to account for the largest share of the remote patient monitoring market. The large share of this segment is attributed to factors such as the increasing prevalence of various chronic diseases, the rising elderly population, favorable regulatory scenarios, technological advancements in sensor technology, the rising demand for personalized healthcare, and the integration of artificial intelligence and machine learning in monitoring devices.

Among applications, in 2024, the diabetes segment is expected to account for the largest share of the remote patient monitoring market. Diabetes was traditionally viewed as a predominantly inherited disease but is increasingly recognized as a lifestyle-related condition due to its rapid prevalence. The large share of the segment is due to factors such as the utilization of telehealth during diabetes management, the increasing prevalence of diabetes, and the increased need to monitor diabetic patients.

Among end users, in 2024, the home-care settings segment is expected to account for the largest share of the remote patient monitoring market. This segment's large market share is attributed to the growing shift towards home-care settings, the rise in chronic diseases among the elderly, the shortage of healthcare professionals, and increasing consumer awareness regarding the monitoring of chronic conditions through RPM tools.

An in-depth analysis of the geographical scenario of the global remote patient monitoring market provides detailed qualitative and quantitative insights for the five major geographies: North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the global remote patient monitoring market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global remote patient monitoring market. This growth is primarily driven by the increasing healthcare expenditure, rising geriatric population, rising prevalence of chronic diseases, growing consumer awareness, increasing personal disposable incomes, and a large target population, thereby supporting the market growth.

The key players operating in the global remote patient monitoring market are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.).

Scope of the Report:

Remote Patient Monitoring Market Assessment-by Product

  • Monitoring Devices
    • Monitoring Devices, by Functionality
  • Blood Glucose Monitoring Devices
  • Cardiac Monitoring Devices
  • Neurological Monitoring Devices
  • Respiratory Monitoring Devices
  • Multiparameter Monitoring Devices
  • Blood Pressure Monitoring Devices
  • Fetal and Neonatal Monitoring Devices
  • Weight Monitoring Devices
  • Other Monitoring Devices

Note: Other monitoring devices include temperature monitors, brain monitoring (EEG), and prothrombin monitors.

    • Monitoring Devices, by Type
  • Wearable Monitoring Devices
  • Portable Monitoring Devices
  • Bench-top Monitoring Devices
  • Software
  • Services

Remote Patient Monitoring Market Assessment-by Application

  • Diabetes
  • Cardiovascular Diseases
  • Neurological Diseases
  • Respiratory Diseases
  • Oncology
  • Other Applications

Note: Other applications include maternity care, post-surgery monitoring, elderly care, medical adherence, and sleep monitoring.

Remote Patient Monitoring Market Assessment-by End User

  • Home-care Settings
  • Hospitals
  • Long-term Care Facilities
  • Other End Users

Note: Other end users include ambulatory care, healthcare payers, and clinical research organizations

Remote Patient Monitoring Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition And Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency And Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection And Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research / Interviews With Key Opinion Leaders of The Industry
  • 2.3. Market Sizing And Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions For The Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Remote Patient Monitoring Market: Regulatory Analysis
    • 4.3.1. Overview
    • 4.3.2. North America
      • 4.3.2.1. U.S.
      • 4.3.2.2. Canada
    • 4.3.3. Europe
    • 4.3.4. Asia-Pacific
      • 4.3.4.1. China
      • 4.3.4.2. Japan
      • 4.3.4.3. India
    • 4.3.5. Latin America
    • 4.3.6. Middle East
  • 4.4. Pricing Analysis
  • 4.5. Industry Trends
    • 4.5.1. Shift From Physician-Driven to Consumer-Driven Healthcare
    • 4.5.2. Integration of Artificial Intelligence With Remote Patient Monitoring Technologies
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Buyers
    • 4.6.2. Bargaining Power of Suppliers
    • 4.6.3. Threat of Substitutes
    • 4.6.4. Threat of New Entrants
    • 4.6.5. Degree of Competition

5. Remote Patient Monitoring Market Assessment- by Product

  • 5.1. Overview
  • 5.2. Monitoring Devices
    • 5.2.1. Monitoring Devices, by Functionality
      • 5.2.1.1. Blood Glucose Monitoring Devices
      • 5.2.1.2. Cardiac Monitoring Devices
      • 5.2.1.3. Neurological Monitoring Devices
      • 5.2.1.4. Respiratory Monitoring Devices
      • 5.2.1.5. Multiparameter Monitoring Devices
      • 5.2.1.6. Blood Pressure Monitoring Devices
      • 5.2.1.7. Fetal And Neonatal Monitoring Devices
      • 5.2.1.8. Weight Monitoring Devices
      • 5.2.1.9. Other Monitoring Devices
    • 5.2.2. Monitoring Devices, by Type
      • 5.2.2.1. Wearable Monitoring Devices
      • 5.2.2.2. Portable Monitoring Devices
      • 5.2.2.3. Bench-Top Monitoring Devices
  • 5.3. Software
  • 5.4. Services

6. Remote Patient Monitoring Market Assessment-by Application

  • 6.1. Overview
  • 6.2. Diabetes
  • 6.3. Cardiovascular Diseases
  • 6.4. Neurological Disorders
  • 6.5. Respiratory Diseases
  • 6.6. Oncology
  • 6.7. Other Applications

7. Remote Patient Monitoring Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Home-Care Settings
  • 7.3. Long-Term Care Facilities
  • 7.4. Hospitals
  • 7.5. Other End Users

8. Remote Patient Monitoring Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. U.K.
    • 8.3.3. France
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies

10. Company Profiles

  • 10.1. Medtronic plc
  • 10.2. Koninklijke Philips N.V.
  • 10.3. Omron Corporation
  • 10.4. Boston Scientific Corporation
  • 10.5. Abbott Laboratories
  • 10.6. Siemens Healthineers AG
  • 10.7. Ge Healthcare Technologies, Inc.
  • 10.8. F. Hoffmann-La Roche AG
  • 10.9. Baxter International Inc.
  • 10.10. Oracle Corporation
  • 10.11. Dexcom, Inc.
  • 10.12. VitalConnect, Inc.
  • 10.13. Other Companies

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports